Concepedia

Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 96-week results of a randomised, double-blind, non-inferiority, phase 3 trial

Jean‐Michel Molina, Kathleen Squires, Paul E. Sax, Pedro Cahn, Johan Lombaard, Edwin DeJesus, Ming‐Tain Lai, Anthony Rodgers, Lisa Lupinacci, Sushma Kumar,

The Lancet HIV · 2019 · 96 citations · 17 references

DOI

Concepts

References

17

Comparative analysis of two rates

Olli S. Miettinen, Markku Nurminen · Statistics in Medicine · 1985 · 1.1K citations

, , +16

Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis

Anthony Mills, Mark Nelson, Dushyantha Jayaweera et al. · AIDS · 2009 · 266 citations

, , +17

Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study

Jean‐Michel Molina, Bonaventura Clotet, Jan van Lunzen et al. · The Lancet HIV · 2015 · 223 citations

, , +14

Brief Report

Sharon Walmsley, Axel Baumgarten, Juan Berenguer et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2015 · 219 citations · Full text

, , +17

Genotypic and Phenotypic Characterization of HIV-1 Isolates Obtained From Patients on Rilpivirine Therapy Experiencing Virologic Failure in the Phase 3 ECHO and THRIVE Studies

L Rimsky, Johan Vingerhoets, Veerle Van Eygen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 175 citations

, , +14